Regencell Bioscience Holdings Ltd
RGC- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001829667
No open-market purchases or sales by Regencell Bioscience Holdings Ltd insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $8.56M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Regencell Bioscience Holdings Ltd changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 16 | 17 | +1 |
| Shares | 633.8K | 548.4K | −85.4K (−13.5%) |
| Value | $9.79M | $11.5M | +$1.73M (+17.6%) |
New holders (7)
Institutions that held Regencell Bioscience Holdings Ltd at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Hudson Bay Capital Management LP | 13,107 | $275.2K | 0.00% |
| Seven Fleet Capital Management LP | 4,400 | $92.4K | 0.06% |
| EverSource Wealth Advisors, LLC | 550 | $11.6K | 0.00% |
| Quarry LP | 468 | $9.83K | 0.00% |
| Northwestern Mutual Wealth Management Co | 301 | $6.32K | 0.00% |
| Ronald Blue Trust, Inc. | 216 | $4.54K | 0.00% |
| Rockefeller Capital Management L.P. | 75 | $1.57K | 0.00% |
Sold out (6)
Institutions that held Regencell Bioscience Holdings Ltd at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Discovery Capital Management, LLC | 46,166 | $713.3K |
| Jane Street Group, LLC | 10,616 | $164.0K |
| BNP Paribas Arbitrage, SA | 4,682 | $72.3K |
| Tower Research Capital LLC (TRC) | 357 | $5.52K |
| Simplex Trading, LLC | 217 | $3.00K |
| Group One Trading, L.P. | 100 | $1.54K |